ARTICLES BY THIS AUTHOR
- 7/25/2021
Number of medico-legal cases dropped in 2020 as advice calls soared: CMPA annual report
Highlights from the Canadian Medical Protective Association's annual report. - 7/25/2021
Quebec offers 3rd dose of COVID vaccine to AstraZeneca recipients who want to travel
Robert Maranda, a spokesman for the Health Department, says there are no studies that assess the impact of receiving three doses of two separate vaccines. - 7/25/2021
The new topicals – So much more than pain relief & pediatrics in the age of polypharmacy
Over-the-counter consults, prescription counselling, and medication reviews are excellent opportunities to educate patients on the benefits of topical alternatives. - 7/22/2021
Halifax alcohol prescription program sees success according to organizers
The initial COVID-19 lockdown drove the program’s creation in a bid to stop the virus’ spread. - 7/22/2021
'Don't look away': Doctor decries clearing of Toronto park homeless encampment, police violence
On Wednesday, a Toronto Police operation sought to evict a group of 14 to 17 homeless individuals (by city estimate) encamped at Lamport Stadium Park. - 7/22/2021
Blockchain and pharmacies: How technology can make selling medical cannabis safer
Many patients swear by medical cannabis as an effective treatment for a wide swathe of ailments and symptoms, including chronic pain, opioid dependency, nausea, sleep disturbances, and anxiety. - 7/22/2021
Working in my neighbourhood
It is not always easy to work in your own neighbourhood as a doctor. But I have spent my entire family medicine career taking care of my neighbours, I see them outside, we walk our dogs together. - 7/22/2021
Poll: Are nursing shortages affecting you?
Several provinces are experiencing nursing shortages, with headlines declaring that many in the country are simply quitting after the strain of the pandemic so far. Are these shortages affecting your workplace? - 7/22/2021
European agency is 1st to clear Moderna jab for children
Until now, the vaccine made by Pfizer and German partner BioNTech has been the only option for children as young as 12 in North America and Europe.